Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $45 at Needham
Tweet
Share
E-mailGet Alerts HRMY Hot Sheet
Price: $36.35 -0.16%
Rating Summary:
10 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 10 | New: 23
Rating Summary:
10 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 10 | New: 23
Join SI Premium – FREE
Needham analyst Ami Fadia raised the price target on Harmony Biosciences Holdings Inc. (NASDAQ: HRMY) to $45.00 (from $44.00) while maintaining a Buy rating.
You May Also Be Interested In
- X-Energy Inc (XE) PT Lowered to $34 at UBS
- Osaka Organic Chemical Industry Ltd (4187:JP) PT Raised to JPY7,400 at Morgan Stanley
- Kura Sushi USA Inc. (KRUS) PT Lowered to $70 at DA Davidson Ahead of Q3 Results
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
